Ahmet Demir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ahmet Demir has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Birdal Yıldırım
MUĞLA SITKI KOÇMAN ÜNİVERSİTESİ, TIP FAKÜLTESİ
3 shared publications - Ethem Acar
MUĞLA SITKI KOÇMAN ÜNİVERSİTESİ, TIP FAKÜLTESİ
3 shared publications Ali Sasmaz
Türkiye Yüksek İhtisas Hospital, Cardiology Clinic, Ankara, Turkey
1 shared publication- Aysel Gokcek
Mugla Sitki Kocman University, Faculty of Medicine, Department of Cardiology, Mugla, Turkey
1 shared publication Ayşegül Kunt
Türkiye Yüksek İhtisas Hospital, Cardiovascular Clinic, Ankara, Turkey
1 shared publication- Ferit Çiçekçioğlu
Department of Cardiovascular Surgery, Ankara Etlik City Hospital, Ankara, Yenimahalle, Türkiye
1 shared publication
Latest Publications
- Open Access
- 1 June 2022
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 23 (2) , 155-161
Magnesium Level in the Mortality Prediction of Community-acquired Pneumonia Patients
- 1 June 2022
- Published by Adnan Menderes University in Meandros Medical and Dental Journal
- Vol. 23 (2) , 155-161
Open AccessMagnesium Level in the Mortality Prediction of Community-acquired Pneumonia Patients
- 23 April 2021
- Published by Ondokuzmayis University, Faculty of Medicine in Journal of Experimental and Clinical Medicine
- Vol. 38 (3) , 383-386
A case of pulmonary thromboembolism with ST elevation and literature review
Electrocardiography (ECG) is an auxiliary test applied for differential diagnosis of Pulmonary Thromboembolism (PTE). However, its specificity is low, but it is more often used for differential diagnosis. Although there are some changes on ECG in PTE, ST elevation is not a finding that we expect to see. With this case report, we aimed to draw attention to the issue with the diagnosis of PTE in a patient with ST elevation in ECG. 52-year-old male patient presented to the emergency department with a complaint of convulsion after chest and back pain. During the examination in the emergency department, he had a convulsion and woke up on his own without entering a postictal phase. After that, he had a chest pain. For this reason, ECG was performed to the patient and revealed ST elevation in leads DI, AVL, V1-4. The results of the patient’s EEG and head computer tomography (CT) were normal, so coronary CT angiography was performed. And it was observed that the coronary arteries were patent but embolism was detected in his cross-sectional pulmonary arteries. Thus, he was treated with the diagnosis of PTE. By the obtained results in this case that ST elevation may be a finding of PE, although it is rare.
- 23 April 2021
- Published by Ondokuzmayis University, Faculty of Medicine in Journal of Experimental and Clinical Medicine
- Vol. 38 (3) , 383-386
A case of pulmonary thromboembolism with ST elevation and literature review
Electrocardiography (ECG) is an auxiliary test applied for differential diagnosis of Pulmonary Thromboembolism (PTE). However, its specificity is low, but it is more often used for differential diagnosis. Although there are some changes on ECG in PTE, ST elevation is not a finding that we expect to see. With this case report, we aimed to draw attention to the issue with the diagnosis of PTE in a patient with ST elevation in ECG. 52-year-old male patient presented to the emergency department with a complaint of convulsion after chest and back pain. During the examination in the emergency department, he had a convulsion and woke up on his own without entering a postictal phase. After that, he had a chest pain. For this reason, ECG was performed to the patient and revealed ST elevation in leads DI, AVL, V1-4. The results of the patient’s EEG and head computer tomography (CT) were normal, so coronary CT angiography was performed. And it was observed that the coronary arteries were patent but embolism was detected in his cross-sectional pulmonary arteries. Thus, he was treated with the diagnosis of PTE. By the obtained results in this case that ST elevation may be a finding of PE, although it is rare.
- Open Access
- 22 April 2021
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (7) , e14256
The role of hemogram parameters and C‐reactive protein in predicting mortality in COVID‐19 infection
Aim This study aimed to investigate hemogram parameters and C‐reactive protein (CRP) that can be used in clinical practice to predict mortality in hospitalized patients with a diagnosis of COVID‐19. Methods This cohort study was conducted at University Hospital, which is a designated hospital for COVID‐19 patients. Adult patients who were admitted to our hospital emergency department with suspected COVID‐19 and who were hospitalized in our institution with a COVID‐19 diagnosis were analysed. Results There were 148 patients hospitalized with COVID‐19. All‐cause mortality of follow‐up was 12.8%. There were statistically significant results between the two groups (survivors and nonsurvivors), which were classified based on hospital mortality rates, in terms of the lymphocyte to C‐reactive protein ratio (LCRP), systemic immune inflammation index (SII), neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), CRP concentration and comorbid disease. In a receiver operating characteristic (ROC), curve analysis, LCRP, NLR, PLR and SII area under the curve (AUC) for in‐hospital mortality were 0.817, 0.816, 0.733 and 0.742, respectively. Based on an LCRP value of 1 for in‐hospital mortality, the sensitivity and specificity rates were 100% and 86.8%, respectively. Based on the average SII of 2699 for in‐hospital mortality, the sensitivity, specificity and accuracy rates were 68.4%, 77.5% and 76.3%, respectively. A total of 19 patients died during hospitalization. All of these patients had an LCRP level ≤ 1; 14 had an NLR level ≤ 10.8; 13 had an SII ≥ 2699 (Fisher's exact test, P = .000). Independent predictors of in‐hospital mortality rates were LCRP < 1, PLR, SII ≥ 2699, white blood cell count, CRP, age, comorbidities, and ICU stay. Conclusions We concluded that inflammatory parameters, such as LRCP, SII and NLR, were associated with disease severity and could be used as potentially important risk factors for COVID‐19 progression.
- 22 April 2021
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (7) , e14256
Open AccessThe role of hemogram parameters and C‐reactive protein in predicting mortality in COVID‐19 infection
Aim This study aimed to investigate hemogram parameters and C‐reactive protein (CRP) that can be used in clinical practice to predict mortality in hospitalized patients with a diagnosis of COVID‐19. Methods This cohort study was conducted at University Hospital, which is a designated hospital for COVID‐19 patients. Adult patients who were admitted to our hospital emergency department with suspected COVID‐19 and who were hospitalized in our institution with a COVID‐19 diagnosis were analysed. Results There were 148 patients hospitalized with COVID‐19. All‐cause mortality of follow‐up was 12.8%. There were statistically significant results between the two groups (survivors and nonsurvivors), which were classified based on hospital mortality rates, in terms of the lymphocyte to C‐reactive protein ratio (LCRP), systemic immune inflammation index (SII), neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), CRP concentration and comorbid disease. In a receiver operating characteristic (ROC), curve analysis, LCRP, NLR, PLR and SII area under the curve (AUC) for in‐hospital mortality were 0.817, 0.816, 0.733 and 0.742, respectively. Based on an LCRP value of 1 for in‐hospital mortality, the sensitivity and specificity rates were 100% and 86.8%, respectively. Based on the average SII of 2699 for in‐hospital mortality, the sensitivity, specificity and accuracy rates were 68.4%, 77.5% and 76.3%, respectively. A total of 19 patients died during hospitalization. All of these patients had an LCRP level ≤ 1; 14 had an NLR level ≤ 10.8; 13 had an SII ≥ 2699 (Fisher's exact test, P = .000). Independent predictors of in‐hospital mortality rates were LCRP < 1, PLR, SII ≥ 2699, white blood cell count, CRP, age, comorbidities, and ICU stay. Conclusions We concluded that inflammatory parameters, such as LRCP, SII and NLR, were associated with disease severity and could be used as potentially important risk factors for COVID‐19 progression.
- Open Access
- 1 March 2007
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 22 (2) , 135-136
Beating-Heart Mitral Valve Reoperation in a Patient With a Permanent Pacemaker
A 60-year-old man with a history of a prior double-valve replacement (DVR) and permanent pacemaker implantation underwent mitral valve reoperation due to a paravalvular leak. Reoperation was performed on a beating heart (BH) on cardiopulmonary bypass, by perfusing the heart continuously with oxygenated noncardioplegic normothermic blood via the coronary sinus. We report the case of a patient who underwent mitral valve reoperation on a beating heart, 10 years after his first double-valve replacement and permanent pacemaker implantation.
- 1 March 2007
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 22 (2) , 135-136
Open AccessBeating-Heart Mitral Valve Reoperation in a Patient With a Permanent Pacemaker
A 60-year-old man with a history of a prior double-valve replacement (DVR) and permanent pacemaker implantation underwent mitral valve reoperation due to a paravalvular leak. Reoperation was performed on a beating heart (BH) on cardiopulmonary bypass, by perfusing the heart continuously with oxygenated noncardioplegic normothermic blood via the coronary sinus. We report the case of a patient who underwent mitral valve reoperation on a beating heart, 10 years after his first double-valve replacement and permanent pacemaker implantation.
- Open Access
- 1 January 2003
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 14 (1) , 28-31
Increased Dispersion of Refractoriness in Patients with Atrial Fibrillation in the Early Postoperative Period after Coronary Artery Bypass Grafting
Preoperative EP Characteristics of Post‐CABG AF. Introduction: Increased atrial effective refractory period (AERP) dispersion is well correlated with vulnerability to atrial fibrillation (AF). However, the preoperative electrophysiologic characteristics of atrial abnormalities that may play an important role in the development of AF postoperatively in patients with coronary artery bypass grafting (CABG) have not been investigated in detail. Methods and Results: Fifty‐six consecutive patients who underwent CABG were enrolled in this study. Eighteen patients (14 men and 4 women; mean age 57.7 ± 5.2 years ) with AF in the early postoperative period and 38 patients (28 men and 10 women; mean age 56.3 ± 6.4 years ) without AF were compared with regard to preoperative clinical, echocardiographic, angiographic, and electrophysiologic parameters. Preoperative PA interval and AERP dispersion values were higher (P < 0.05) in patients who developed AF in the early postoperative period. PA interval ( P < 0.05 , odds ratio = 1.64, 95% confidence interval 1.17–2.30), AERP in the high right atrium (AERPHRA; P < 0.05 , odds ratio = 0.94, 95% confidence interval 0.91–0.97), AERP in the right posterolateral atrium (AERPRPL; P < 0.05 , odds ratio = 0.79, 95% confidence interval 0.63–0.98), AERP in the distal coronary sinus (AERPDCS; P < 0.05 , odds ratio = 0.84, 95% confidence interval 0.74–1.02), and AERP dispersion ( P < 0.001 , odds ratio = 1.29, 95% confidence interval 1.12–1.47) were independently related to post‐CABG AF in univariate analysis. Increases in preoperative PA interval and AERP dispersion were found to be associated with a high risk for development of post‐CABG AF. Conclusion: AERP dispersion is a suitable electrophysiologic indicator for atrial vulnerability. The presence of increased preoperative AERP dispersion and PA interval may indicate patients at high risk for development of AF in the early postoperative period after coronary artery bypass grafting.
- 1 January 2003
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 14 (1) , 28-31
Open AccessIncreased Dispersion of Refractoriness in Patients with Atrial Fibrillation in the Early Postoperative Period after Coronary Artery Bypass Grafting
Preoperative EP Characteristics of Post‐CABG AF. Introduction: Increased atrial effective refractory period (AERP) dispersion is well correlated with vulnerability to atrial fibrillation (AF). However, the preoperative electrophysiologic characteristics of atrial abnormalities that may play an important role in the development of AF postoperatively in patients with coronary artery bypass grafting (CABG) have not been investigated in detail. Methods and Results: Fifty‐six consecutive patients who underwent CABG were enrolled in this study. Eighteen patients (14 men and 4 women; mean age 57.7 ± 5.2 years ) with AF in the early postoperative period and 38 patients (28 men and 10 women; mean age 56.3 ± 6.4 years ) without AF were compared with regard to preoperative clinical, echocardiographic, angiographic, and electrophysiologic parameters. Preoperative PA interval and AERP dispersion values were higher (P < 0.05) in patients who developed AF in the early postoperative period. PA interval ( P < 0.05 , odds ratio = 1.64, 95% confidence interval 1.17–2.30), AERP in the high right atrium (AERPHRA; P < 0.05 , odds ratio = 0.94, 95% confidence interval 0.91–0.97), AERP in the right posterolateral atrium (AERPRPL; P < 0.05 , odds ratio = 0.79, 95% confidence interval 0.63–0.98), AERP in the distal coronary sinus (AERPDCS; P < 0.05 , odds ratio = 0.84, 95% confidence interval 0.74–1.02), and AERP dispersion ( P < 0.001 , odds ratio = 1.29, 95% confidence interval 1.12–1.47) were independently related to post‐CABG AF in univariate analysis. Increases in preoperative PA interval and AERP dispersion were found to be associated with a high risk for development of post‐CABG AF. Conclusion: AERP dispersion is a suitable electrophysiologic indicator for atrial vulnerability. The presence of increased preoperative AERP dispersion and PA interval may indicate patients at high risk for development of AF in the early postoperative period after coronary artery bypass grafting.